Claude designs protein binders for 14/15 targets, sparking debate on two LLM drug discovery paradigms
AllThingsApx · x · 2026-08-19
Anthropic published a blog showing Claude autonomously designed de novo protein binders for 14 out of 15 targets from an expert-written prompt; Adaptyv Bio and Twist Bioscience independently built and tested the designs.
Commenter Chris Hayduk compared it to Rowan's small-molecule binder post from the day before: Rowan used minimal tooling (even running Claude Opus 5 without RDKit by accident), while Anthropic gave Claude state-of-the-art binder design tools with the model acting as orchestrator. He frames these as two visions of LLMs in drug discovery—model-as-orchestrator vs model-cures-by-intelligence—and finds Anthropic's result impressive but unsurprising, since the task mainly tested coherent long-horizon iterative tool calling that Opus-4.6-class models might already handle.
Related event: Anthropic Says Claude Designed Protein Binders for 14 of 15 Targets(45 posts)→
More from Research
- Interp researcher pushes back: if you can't simulate a neuron, you haven't explained it — nabla_theta · 2026-10-16
- MLP-Splatting (ECCV 2026) code released: MLPs as light-field primitives instead of Gaussians — AjdDavison · 2026-10-16
- Four-page solution to subcubic APSP builds intuition for Anthropic-AI-aided breakthrough — gautamcgoel · 2026-10-16
- ATAS: Zhejiang-led team builds world-state memory framework for consistent agentic video generation — CSProfKGD · 2026-10-16
- Hermes: a 4B model with 8K context got worse with more test-time compute, pointing to contextual reasoning — mangahomanga · 2026-10-16
- Microsoft Research unveils Magnetar, the fastest zkVM at 10-39x speedups and post-quantum security — jedisct1 · 2026-10-16